275 related articles for article (PubMed ID: 21618531)
1. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
3. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
4. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
Brehme M; Voisine C
Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
[TBL] [Abstract][Full Text] [Related]
5. A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
Hadizadeh Esfahani A; Sverchkova A; Saez-Rodriguez J; Schuppert AA; Brehme M
PLoS Comput Biol; 2018 Jan; 14(1):e1005890. PubMed ID: 29293508
[TBL] [Abstract][Full Text] [Related]
6. Chemical Biology Framework to Illuminate Proteostasis.
Sebastian RM; Shoulders MD
Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
[TBL] [Abstract][Full Text] [Related]
7. Protein homeostasis as a therapeutic target for diseases of protein conformation.
Calamini B; Morimoto RI
Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
[TBL] [Abstract][Full Text] [Related]
8. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
9. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
10. Chaperones and multitasking proteins in the nucleolus: networking together for survival?
Bański P; Kodiha M; Stochaj U
Trends Biochem Sci; 2010 Jul; 35(7):361-7. PubMed ID: 20363631
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
Karatas E; Bouchecareilh M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
[TBL] [Abstract][Full Text] [Related]
12. Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis.
Trougakos IP; Sesti F; Tsakiri E; Gorgoulis VG
J Proteomics; 2013 Oct; 92():274-98. PubMed ID: 23500136
[TBL] [Abstract][Full Text] [Related]
13. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
[TBL] [Abstract][Full Text] [Related]
14. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
[TBL] [Abstract][Full Text] [Related]
15. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
16. Extracellular chaperones.
Dabbs RA; Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
Top Curr Chem; 2013; 328():241-68. PubMed ID: 22076079
[TBL] [Abstract][Full Text] [Related]
17. Extracellular protein homeostasis in neurodegenerative diseases.
Wilson MR; Satapathy S; Vendruscolo M
Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
[TBL] [Abstract][Full Text] [Related]
18. Extracellular chaperones and proteostasis.
Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
Annu Rev Biochem; 2013; 82():295-322. PubMed ID: 23350744
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
Tao YX; Conn PM
Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
[TBL] [Abstract][Full Text] [Related]
20. The family of mammalian small heat shock proteins (HSPBs): implications in protein deposit diseases and motor neuropathies.
Boncoraglio A; Minoia M; Carra S
Int J Biochem Cell Biol; 2012 Oct; 44(10):1657-69. PubMed ID: 22484489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
